A B S T R A C T Coronary responses to adrenergic stimuli were determined in the intact beating heart before and after administration of practolol, 4-(2-hydroxy-3-isopropylaminoproproxy) acetanilide, which in low doses blocks myocardial but not vascular beta receptors. The left circumflex coronary artery of dogs was perfused with arterial blood at constant flow, and coronary perfusion pressure was measured.
INTRODUCTION
Adrenergic stimuli influence coronary vascular resistance directly through effects on coronary vessels and indirectly through myocardial effects (2) . Previous attempts to determine the direct vascular effects by eliminating the myocardial component. included studies of coronary responses in fibrillating or arrested hearts (3) (4) (5) or in isolated vessels (6) . Until recently, it has been difficult to separate direct and indirect effects in the beating heart because drugs which blocked beta receptors in the myocardium also antagonized beta receptors in coronary vessels.
In these experiments, coronary vascular responses to adrenergic stimuli were studied in the intact beating heart before and after administration of practolol, a new drug which in low doses antagonizes selectively myocardial, but not vascular, beta receptors (7).
METHODS
Mongrel dogs weighing 19-25 kg were anesthetized with chloralose, 50 mg/kg, and urethane, 500 mg/kg. The animals were treated with decamethonium bromide, 0.3 mg/kg, and ventilated artificially with room air and supplemental oxygen. Through a left thoracotomy, a segment of the left circumflex coronary artery was cannulated and perfused at constant flow (40-60 ml/min) with heparinized blood from a femoral artery using a peristaltic pump (Fig. 1) . Initially, flow rate was adjusted so that coronary perfusion pressure approximated systemic arterial pressure; this rate then was maintained for the rest of the experiment. With flow constant, changes in perfusion pressure reflected changes in coronary vascular resistance. Perfusion pressure fell abruptly to [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Responses to stimuli were taken as peak changes in perfusion pressure. In addition to perfusion pressure, aortic and left ventricular pressures, left ventricular dp/dt (LV dp/dt), and heart rate were recorded. LV dp/dt was obtained using a No. 7F cardiac catheter, a Statham P 23 Db pressure transducer, and an RC differentiating circuit with a time constant of 0.5 msec. Beat-to-beat changes in rate were measured using a cardiotachometer. Drugs used as agonists were isoproterenol hydrochloride, l-norepinephrine bitartrate, glyceryltrinitrate, and val5-angiotensin-II amide. Fresh solutions were prepared for each experiment using appropriate dilutions of stock solutions in 5% dextrose and water. The agonists were injected into the perfusion tubing upstream from the pump in volumes of 0.02-0.2 ml; injections of these volumes of dextrose solution alone had no effect. The left cardiac nerves were sectioned close to the left stellate ganglion and stimulated at 10 v with cycles of 4 msec duration at variable frequency. Antagonists used in the study were practolol,' propranolol hydrochloride, and phentolamine mesylate. Statistical comparisons were made using the t test for paired data (8) . produced small but significant increases in coronary perfusion pressure associated with decreases in LV dp/dt without significant changes in heart rate or arterial pressure (Table I) .
RESULTS

Effects
Before administration of practolol, isoproterenol, sympathetic nerve stimulation, and norepinephrine caused reductions in perfusion pressure accompanied by increases in LV dp/dt, heart rate, and systolic pressure (Table II and Figs. 2 and 3 ). Small transient increases in perfusion pressure often preceded the reductions with nerve stimulation (Fig. 3) and norepinephrine, but not with isoproterenol ( Fig. 2) .
After administration of practolol, isoproterenol produced reductions in perfusion pressure which were smaller than those observed before practolol, but these occurred without significant increases in LV dp/dt, heart rate, and arterial pressure (Table II and Fig. 2 ). In contrast, practolol reversed the effect of both nerve stimulation ( Fig. 3 ) and norepinephrine from decreases to increases in perfusion pressure (Table II) ; increases in dp/dt, heart rate and arterial pressure were reduced or blocked by practolol (Table II) .
Glyceryltrinitrate, 3 and 6 glg, was used as an internal dilator control and produced decreases in perfusion pressure which averaged 26 ±2. values after practolol were not significantly different and averaged 19 ±1.7 and 27 ±2.6 mm Hg, respectively. These responses occurred without changes in arterial pressure, heart rate, or LV dp/dt.
Effects of propranolol after practolol. Propranolol blocked completely the decreases in perfusion pressure caused by isoproterenol (Table III) . The increases in perfusion pressure seen in response to nerve stimulation and norepinephrine after practolol were not augmented by propranolol (Table III) . Angiotensin, 0.25 tg, used as an internal constrictor control, produced increases in perfusion pressure averaging 28 ±5.9 mm Hg after practolol and 25 ±9.4 mm Hg after subsequent administration of propranolol.
Effects of phentolamine after practolol. The constrictor responses to nerve stimulation and norepinephrine after practolol were reduced and reversed, respectively, by intracoronary administration of phentolamine, 1 mg (Fig. 4) . Responses to angiotensin were not altered (Fig. 4) .
Responses in hind paw. The dilator responses to isoproterenol and glyceryltrinitrate were not altered by practolol (Fig. 5) .
DISCUSSION
Practolol reduced the coronary response to isoproterenol, but significant dilatation with isoproterenol persisted Exp. 385 (left) and after (right) iis possibility is remote since we selected a tolol which was too small to block vascular rs, yet sufficient to block the mvocardial adrenergic stimuli. Dunlap and Shanks mne mg/kg of practolol given locally did increases in iliac blood flow produced by (7) . In the present study we confirmed the ineffectiveness of this dose of practolol in blocking vascular beta receptors in the hind paw. It is possible that much larger doses of practolol would block vascular beta receptors in the coronary as well as other vessels (7, 9) just as propranolol did in this study. We did not administer larger doses of practolol because our aim was not to study the action of practolol at various dose levels but rather to use this drug as a pharmacologic tool to separate the changes in coronary resistance which reflect indirect myocardial effects from those which represent direct vascular effects.
The second possibility was that the decreased dilator responses after practolol resulted from inhibition of the myocardial effects of isoproterenol. This explanation seemed more likely because results of other investigators (2, 4) and the present experiments indicate that increases in myocardial contractility and metabolism resulting from administration or release of norepinephrine produce coronary vasodilatation which is reversed after blockade or partial suppression of the myocardial response.
The third explanation may be that the reduction in responsiveness may be nonspecific. is both direct and indirect, resulting from stimulation of vascular and myocardial beta receptors, with the direct vascular effect predominating in this study. Earlier studies of coronary reactivity in arrested hearts (3) or isolated vessels (6) demonstrated that isoproterenol activates beta receptors in these vessels. The present *experiments in the beating heart support and these and other more recent observations (9) . The recent findings of Ross and Jorgensen (9) also would support the conclusion that the coronary dilator action of isoproterenol is predominantly the result of a direct vascular effect.
In contrast with isoproterenol, the coronary dilator response to norepinephrine and nerve stimulation is an indirect effect resulting from stimulation of beta receptors in the myocardium; the direct effect on coronary vessels is vasoconstriction which is minimal compared with that seen with the same stimuli in other vascular beds (10) . Administration of phentolamine, an alpha receptor blocking agent, reduced the constriction with nerve stimulation and reversed the response to norepinephrine from constriction to slight dilatation. The effect of angiotensin used as an internal control was not altered by phentolamine. We considered the possibility that constrictor responses to norepinephrine and nerve stimulation seen after practolol resulted from residual increases in left ventricular pressure and wall tension, but this seemed unlikely since these responses often occurred without such increases and were blocked by phentolamine. We did not attempt to block the slight dilator response which was seen with norepinephrine after practolol and phentolamine. Instead, we tried to determine if norepinephrine and nerve stimulation produced significant stimulation of coronary vascular beta receptors by comparing responses after practolol alone with responses after practolol plus propranolol. Addition of propranolol did not augment the constriction suggesting that vascular beta receptors do not play an important role in the coronary responses to nerve stimulation or norepinephine.
